‘India not to stop hydroxychloroquine treatment in mild cases'

​​HCQ, currently used to treat lupus and rheumatoid arthritis, has split world opinion on its use in Covid-19 management, even as India said the decision was “taken based on risk-benefit assessment.”
Source: The Economic Times - Category: Consumer Health News Source Type: news